Glucagon-like peptide-1 induces cell proliferation and pancreatic-duodenum homeobox-1 expression and increases endocrine cell mass in the pancreas of old, glucose-intolerant rats

Endocrinology

Volumn 141, Issue 12, 2000, Pages 4600-4605

  Perfetti, Riccardo ^a   Zhou, J I E ^b   Doyle, Máire E ^b   Egan, Josephine M ^b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXENDIN; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; HORMONE ANTAGONIST; INSULIN; PANCREATIC DUODENUM HOMEOBOX 1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; HORMONE DETERMINATION; INSULIN RELEASE; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 0034522773     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.141.12.7806     Document Type: Article

References (22)

1. Age-dependent reduction in insulin secretion and insulin mRNA in isolated islets from rats
2. Glucagon-like peptide-1 can reverse the age-related decline in glucose tolerance in rats
3. Glucagon-like peptide-1 and the control of insulin secretion in the normal state and in NIDDM
4. Normalization of fasting hyperglycemia by exogenous glucagon-like peptide 1 (7-36) amide in type 2 (non-insulin-dependent) diabetic patients
5. Continuous subcutaneous infusion of glucagon-like peptide lowers plasma glucose and reduces appetite in type 2 diabetic subjects
6. Glucagon-like peptide-1 regulates the beta cell transcription factor, PDX-1, in insulinoma cells
7. Insulin-promoter-factor-1 is required for pancreas development in mice
8. Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence
9. A newly discovered role of transcription factors involved in pancreatic development and the pathogenesis of type 2 diabetes mellitus
10. Once daily injections of Exendin-4 to diabetic mice achieves long-term beneficial effects on blood glucose levels
11. Glucagon-like peptide-1 is a physiological incretin in man
12. Rapid detection of octamer binding proteins with "mini-extracts", prepared from a small number of cells
13. GLP-1 and Exendin-4 convert AR42J cells into insulin- and glucagon-containing cells
14. Role of apoptosis in failure of β-cell mass compensation for insulin resistance and β-cell defects in the male Zucker diabetic fatty rat
15. Adult insulin- and glucagon-producing cells differentiate from two independent cell lineages
16. Glucagon-like peptide-1 promotes DNA synthesis, activates phosphatidylinositol 3-kinase and increases transcription factor pancreatic and duodenal homeobox gene 1 (PDX-1) DNA binding activity in beta (INS-1)-cells
17. Exendin-4 stimulates both β-cell replication and neogenesis, resulting in increased β-cell mass and improved glucose tolerance in diabetic rats
18. Missense mutations in the insulin promoter factor-1 gene predispose to type 2 diabetes
19. Defective mutations in the insulin promoter factor-1 (IPF-1) gene in late-onset type 2 diabetes mellitus
20. Hyperglycemic progression in subjects with impaired glucose tolerance: Association with decline in beta cell function
21. Transcriptional activation of the GLUT2 gene by IPF-1/STF-1/IDX-1 homeobox domain
22. Insulinotropic glucagon-like peptide-1 agonists stimulate expression homeoprotein IDX-1 and increase islet mass in mouse pancreas